-
1مورد إلكتروني
المؤلفون: Lieberman, R
المصدر: Urology; vol 57, iss 4 Suppl 1, 4-27; 0090-4295
مصطلحات الفهرس: Humans, Prostatic Neoplasms, Antineoplastic Agents, Anticarcinogenic Agents, Government, National Institutes of Health (U.S.), United States Food and Drug Administration, Drug Industry, Middle Aged, Interinstitutional Relations, United States, Male, Clinical Trials as Topic, Practice Guidelines as Topic, Biomarkers, Tumor, Orphan Drug, Urologic Diseases, Cancer, Prevention, Rare Diseases, Prostate Cancer, Clinical Research, Clinical Trials and Supportive Activities, Aging, Development of treatments and therapeutic interventions, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, 5.1 Pharmaceuticals, Prevention of disease and conditions, and promotion of well-being, 3.3 Nutrition and chemoprevention, Clinical Sciences, Urology & Nephrology, article
-
2مورد إلكتروني
المؤلفون: Lieberman, R
المصدر: Urology; vol 57, iss 4 Suppl 1, 4-27; 0090-4295
مصطلحات الفهرس: Humans, Prostatic Neoplasms, Antineoplastic Agents, Anticarcinogenic Agents, Government, National Institutes of Health (U.S.), United States Food and Drug Administration, Drug Industry, Middle Aged, Interinstitutional Relations, United States, Male, Clinical Trials as Topic, Practice Guidelines as Topic, Biomarkers, Tumor, Urology & Nephrology, Clinical Sciences, article